Combined Flywheel Resistance and Aerobic Exercise on Power output and Function in Chronic Kidney Disease: An Exploratory Study on the Influence of Physical Activity

ABSTRACT

New Findings What is the central question of this study? Are adaptations elicited by combined flywheel resistance and aerobic exercise influenced by habitual physical activity levels in patients with chronic kidney disease?

What is the main finding and its importance? Combined flywheel resistance and aerobic exercise promote clinically meaningful improvements in muscle size, power output, and physical function in patients with chronic kidney disease. Those not meeting the weekly moderate intensity physical activity recommendations experienced greater increases in power output compared to those who were physically active whereas no differences in the magnitude of improvements in physical function were observed between physical activity levels.

Physical inactivity is common in chronic kidney disease (CKD) and is associated with poor neuromuscular and functional outcomes. Whether habitual physical activity (PA) influences adaptations to structured exercise in CKD remains unclear. This study examined if adaptations to combined flywheel resistance and aerobic exercise (FRE+AE) differed based on self-reported PA in Veterans with CKD stages 3–4. Twenty older male Veterans with CKD stages 3-4 (mean eGFR 37.9 ± 10.2 mL/min/1.73 m²) were randomized to six weeks of FRE+AE (n=11) or health education (EDU; n=9). Participants were classified as meeting (Meets PA) or below (Low PA) weekly moderate intensity PA recommendations using the 7-day Physical Activity Recall. Outcomes included vastus lateralis muscle thickness (VL MT), knee extensor power output (60°·s-1 and 180°·s-1), gait speed (GS), and five-repetition sit-to-stand (STS). FRE+AE increased VL MT (p=0.030), power output at 180°/s (p=0.021), GS (p=0.001), and reduced STS time (p=0.012), with significant between-group differences versus EDU for VL MT (p=0.009) and GS (p=0.028). Low PA experienced greater increases in power output at 60°·s-1 (Hedge’s g; Low PA=0.44, Meets PA=0.25) and 180°·s-1 (Hedge’s g; Low PA=1.38, Meets PA=0.38) compared to Meets PA after FRE+AE. Conversely, Meets PA had greater improvements in GS (Hedge’s g; Low PA=0.93, Meets PA=1.29) and STS (Hedge’s g; Low PA=-0.72, Meets PA=-2.20) compared to Low PA. Six weeks of FRE+AE produced clinically meaningful neuromuscular and functional improvements in Veterans with CKD stages 3-4 irrespective of PA level, supporting FRE+AE as a feasible intervention in this population.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04397159

Funding Statement

This study was funded by the United States Department of Veterans Affairs, Office of Research and Development, Rehabilitation Research, Development, and Translation (RRDT) Section Career Development Award (CDA-2) 1IKRX003423 to J.M.G. and RRDT Senior Research Career Scientist Award IK6 RX003977 to A.S.R.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Review Board and Research & Development Committee of the Washington DC VA Medical Center gave ethical approval of this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Comments (0)

No login
gif